Patricia Moriel

12PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMolecular targetsPharmacogenomicsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 27, 2025
Dysregulated lncRNAs in Cisplatin-Induced Nephrotoxicity and Their Association with Apoptosis and Autophagy: An Exploratory In Vitro Study.

Yuliannis Lugones, Pía Loren, Carola E Matus

|Apr 26, 2025
Association of ABC Efflux Transporter Genetic Variants and Adverse Drug Reactions and Survival in Patients with Non-Small Lung Cancer.

Cecilia Souto Seguin, Giovana Fernanda Santos Fidelis, Carolina Dagli-Hernandez

|Aug 29, 2024
Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile.

Mariana Vieira Morau, Cecilia Souto Seguin, Mauricio Wesley Perroud Junior

|Oct 17, 2023
Challenges for the application of pharmacogenomics associated with the nomenclature of allelic variants.

Nadine de Godoy Torso, Paulo Caleb Jl Santos, Patricia Moriel

|Jul 14, 2023
Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin.

Nadine de Godoy Torso, Julia Coelho França Quintanilha, Maria Aparecida Cursino

|Jan 08, 2023
Assessment of Renal Function in Head and Neck Cancer Patients Treated with Cisplatin: Different Biomarkers and Acute Kidney Injury Classifications.

Nadine de Godoy Torso, Marília Berlofa Visacri, Julia Coelho França Quintanilha

Pageof 2

Frequent Collaborators

5 joint publications

Marília Berlofa Visacri

5 joint publications

Nadine de Godoy Torso

4 joint publications

Pedro Ens Vasconcelos

4 joint publications

Eder de Carvalho Pincinato